WHAT YOU NEED TO KNOW
|U.S. stock futures were poised for gains on Monday morning with investors’ confidence boosted by the return of COVID-19 vaccine trials by pharmaceutical company AstraZeneca. The company halted trails early last week when safety concerns triggered calls for an independent review. AstraZeneca’s trials will resume only in the UK, while those in the U.S. and other countries remain on hold. |
Pharmaceutical companies BioNTech and Pfizer will expand their Phase 3 vaccines to incorporate a more diverse population, including adolescents as young as 16 and people with stable HIV. The announcement comes as companies report a general push to ensure minorities volunteer for vaccine trials, although they must overcome reluctance to participate that stems from a history of exclusion and mistreatment by medical providers.
Sunday marked six months since President Donald Trump declared a national emergency due to the pandemic, reflecting half a year of massive upheaval. The coronavirus now advances against a backdrop of historic wildfires in California, Oregon and Washington that have so far killed 33 people and destroyed millions of acres of land.
The record-setting speed and breadth of the wildfires will likely raise a fight over climate change ahead of President Trump’s visit to California on Monday. Trump will move West from Nevada, where his campaign on Sunday held its first entirely indoor rally in almost three months, defying local public health directives to limit indoor gatherings.
Evidence of more long-term damage to the U.S. job market is slowly emerging with persistent trends such as upticks in retirement and temporary furloughs that turn permanent. Women who left the job market due to the pandemic have also not returned. Among the sole companies to defy the trend is Amazon, which has announced plans to hire another 100,000 employees in the U.S. and Canada with the shift to online shopping.
Israel is the first country to announce a second nationwide lockdown since the pandemic began, acting on one of the worst per capita rates of infection in the world. The shutdown aims to prevent millions from gathering to celebrate a string of upcoming Jewish holidays that began on Friday with Rosh Hashanah. Countries across Europe are reporting a surge in daily infections, while the World Health Organization this weekend announced a record one-day rise in global infections.
Football officially returned to the U.S. over the weekend, rife with struggles to continue amid the coronavirus and grappling with racial wounds. The NFL’s return was received by fans with mixed feelings of relief for partaking in a ritual that borders on normal, but tension and worry for how the nation will move forward.
NAVIGATING THE PANDEMIC
The disproportionate mental health effects of Covid-19 on Black and Latino populations – Quartz – 9/14/2020
Black and Latino people are more likely than white people in the US to report anxiety or sadness they struggled to cope with during the pandemic, according to a survey of 1,266 people by the Commonwealth Fund, an organization that works to create better healthcare in the US.
|Redesigning The Office To Maximize Health – NPR – 9/14/2020While the scale of the current pandemic is new, the need for architects to prioritize human health is not, says Kevin Van Den Wymelenberg, director of the Institute for Health in the Built Environment. “We’ve designed buildings for 100-year floods,” he says. “Now we have to learn to design for the 100-year flu.”|
Treatments that target the coronavirus in the nose might help prevent COVID-19 – Science News – 9/14/2020
Scientists are developing and testing ways to prevent the virus from settling in to prime nasal real estate. These include a nose spray that smothers and inactivates a key viral protein, disinfectants that are commonly used before sinus surgeries, and even dilute baby shampoo misted up the nose.
This process will determine how quickly we get a coronavirus vaccine – CNN – 9/14/2020
Emergency use authorization is what its name suggests: a medical product that gets special authorization by the US Food and Drug Administration to be used during an emergency. Sometimes it’s a product that has already been FDA-approved, but for another condition, and sometimes it’s a new product that hasn’t yet received the agency’s green light.
|Coronavirus: 10 numbers that sum up the stunning scope of COVID-19 shutdowns – The Mercury News – 9/13/2020|
In the six months since the Bay Area locked down in response to the coronavirus, we have been overwhelmed by a ticker tape of numbers that illustrate how COVID-19 has fundamentally changed our world. The bench for statistics is deep, but here are 10 that we think sum up the stunning scope of the pandemic.
WHAT INFLUENCERS ARE SAYING
Daily Mail US @DailyMail 14 Sep Pfizer CEO says a coronavirus vaccine could be viable by the end of October and ready to be distributed before the New Year
Amesh Adalja @AmeshAA 14 Sep “based on current infection rates, the companies continue to expect that a conclusive readout on efficacy is likely by the end of October”
The Telegraph @ttindia 14 Sep In the race for the coronavirus vaccine, some researchers worry that we may be pinning too many hopes on a strategy that has not been proven
Motilal Oswal Financial Services Ltd @MotilalOswalLtd 14 Sep The global cues were positive overnight as hopes of a coronavirus vaccine were rekindled after AstraZeneca resumed its phase-3 trial while sentiment was still cautious ahead of a big week of central bank meetings in UK, Japan and the United States. #MOMarketUpdates
Neil Saunders @NeilRetail 14 Sep 🇺🇸 Americans who can afford to hoard cash are waiting for a vaccine to spend it
Turbine Labs has tracked 22,241 media articles and blogs over the last 24 hours and 749,140 social media posts over the last 24 hours.